Protective Role of Matrix Metalloproteinase-9 in Ozone-Induced Airway Inflammation by Yoon, Hyoung-Kyu et al.
Environmental Health Perspectives • VOLUME 115 | NUMBER 11 | November 2007 1557
Research
Ozone is a common urban air pollutant
that remains a major health concern.
Epidemiologic studies have demonstrated a
strong association between high ambient O3
concentration with cardiovascular and respi-
ratory morbidity and mortality (Bell et al.
2005). O3 exposure elicits airway inﬂamma-
tion characterized by neutrophil accumula-
tion (Schelegle et al. 1991; Seltzer et al. 1986)
and liberates multiple inflammatory media-
tors, cytokines, and chemokines as an early
inflammatory event (Aris et al. 1993; Koren
et al. 1989). O3-induced activation of airway
neutrophilic infiltration is likely to produce
additional damage through the release of
reactive oxygen species and endogenous
proteolytic enzymes.
Several different kinds of endogenous pro-
teases participate in the pathogenesis of airway
inﬂammation. Among these, matrix metallo-
proteinases (MMPs) belong to a family of
zinc-dependent extracellular enzymes that
share common structural features and have an
important role in many physiological and
pathological conditions (Parks and Shapiro
2001). MMPs are secreted by inflammatory
and noninﬂammatory cells and have a major
role in extracellular matrix (ECM) degrada-
tion, proteolytic modulation of biologically
active proteins, and cell migration (Goetzl
et al. 1996; Kelly et al. 2000; Kheradmand
et al. 2002; Mautino et al. 1997; Parks and
Shapiro 2001). Elevated levels of MMPs are
prominent in inflammatory disorders of the
airway and parenchymal lung disease and
have been also implicated in several pul-
monary diseases characterized by lung tissue
damage, alveolar structure alterations, or
abnormal repair (Elkington and Friedland
2006; Parks and Shapiro 2001). MMPs can
be divided on the basis of their substrate
speciﬁcity into collagenases (MMP-1, 8, 13),
gelatinases (MMP-2, 9), stromelysins
(MMP-3, 10, 11), matrilysin (MMP-7),
macrophage metalloelastase (MMP-12), and
membrane-type (MT)-MMPs (MMP-14, 15,
16, 17) (Visse and Nagase 2003).
Gelatinases degrade many ECM proteins;
most important is type IV collagen, a major
constituent of lung basement membrane
(Nagase and Woessner 1999). Therefore,
gelatinases have been thought to have an
important role in the pathogenesis of various
lung diseases (Nagase and Woessner 1999).
Gelatinases also can cleave a variety of non-
ECM proteins, including cytokines and
chemokines (McQuibban et al. 2000; Yu and
Stamenkovic 2000; Zhang et al. 2003).
MMP-2 (gelatinase A) is produced by a wide
range of cell types in the lung, and it is
increased in lung disorders with oxidative
stress and inﬂammation etiologies (e.g., Pardo
et al. 1998; Perez-Ramos et al. 1999; Tan
et al. 2006). MMP-9 (gelatinase B) has been
implicated in the pathogenesis of asthma
(Cataldo et al. 2000), idiopathic pulmonary
ﬁbrosis (Fukuda et al. 1998), chronic obstruc-
tive pulmonary disease (COPD; Russell et al.
2002), and acute lung injury (Lanchou et al.
2003). In the normal lung, constitutive
expression of MMP-9 is restricted to neu-
trophils and eosinophils. However, MMP-9
induced by inﬂammatory stimuli and proin-
ﬂammatory cytokines is generated in multiple
cell types including alveolar macrophages and
other resident pulmonary cells (Atkinson and
Senior 2003; Chakrabarti and Patel 2005).
MMP-9 is known to be induced by O3 in
murine skin and lung (Kenyon et al. 2002;
Valacchi et al. 2003).
MMP-7 has homeostatic function and a
role in innate immunity in epithelial cells
(Parks and Shapiro 2001). In adult human
lung, MMP-7 is expressed by epithelial cells
lining peribronchial and conducting airway
(Dunsmore et al. 1998). Increased expression
of MMP-7 has been observed in airway and
alveolar cells at sites of lung cancer (Wilson
and Matrisian 1996), idiopathic pulmonary
ﬁbrosis (Zuo et al. 2002), and cystic ﬁbrosis
(Dunsmore et al. 1998). Although it is clear
that MMP-7 is associated with chronic lung
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BACKGROUND: Exposure to ozone causes airway inflammation, hyperreactivity, lung hyper-
permeability, and epithelial cell injury. An early inﬂammatory response induced by inhaled O3 is
characterized primarily by release of inﬂammatory mediators such as cytokines, chemokines, and
airway neutrophil accumulation. Matrix metalloproteinases (MMPs) have been implicated in the
pathogenesis of oxidative lung disorders including acute lung injury, asthma, and chronic obstruc-
tive pulmonary disease.
OBJECTIVE: We hypothesized that MMPs have an important role in the pathogenesis of O3-induced
airway inﬂammation.
METHODS: We compared the lung injury responses in either Mmp7- (Mmp7–/–) or Mmp9-deﬁcient
(Mmp9–/–) mice and their wild-type controls (Mmp7+/+, Mmp9+/+) after exposure to 0.3 ppm O3 or
ﬁltered air.
RESULTS: Relative to air-exposed controls, MMP-9 activity in bronchoalveolar lavage ﬂuid (BALF)
was signiﬁcantly increased by O3 exposure in Mmp9+/+ mice. O3-induced increases in the concen-
tration of total protein (a marker of lung permeability) and the numbers of neutrophils and epithe-
lial cells in BALF were significantly greater in Mmp9–/– mice compared with Mmp9+/+ mice.
Keratinocyte-derived chemokine (KC) and macrophage inflammatory protein (MIP)-2 levels in
BALF were also significantly higher in Mmp9–/– mice than in Mmp9+/+ mice after O3 exposure,
although no differences in mRNA expression for these chemokines were found between genotypes.
Mean BALF protein concentration and numbers of inﬂammatory cells were not signiﬁcantly differ-
ent between Mmp7+/+ and Mmp7–/– mice after O3 exposure.
CONCLUSIONS: Results demonstrated a protective role of MMP-9 but not of MMP-7, in
O3-induced lung neutrophilic inflammation and hyperpermeability. The mechanism through
which Mmp9 limits O3-induced airway injury is not known but may be via posttranscriptional
effects on proinﬂammatory CXC chemokines including KC and MIP-2.
KEY WORDS: chemokine; knockout mice; lung; MMP-9; O3; oxidant. Environ Health Perspect
115:1557–1563 (2007). doi:10.1289/ehp.10289 available via http://dx.doi.org/ [Online 24 August 2007]disease, the role of MMP-7 in O3-induced
airway inﬂammation is still unknown.
In the present studies, we hypothesized
that murine MMP-7 and MMP-9 have
important functional roles in facilitating the
airway inflammatory responses induced by
inhaled O3. To address this hypothesis, we
used mice genetically deficient in Mmp7
(Mmp7, matrix metalloproteinase 7; Entrez
Gene ID 17393, http://www.ncbi.nlm.nih.
gov/sites/entrez?db=gene) and Mmp9 (Mmp9;
matrix metalloproteinase 9; Entrez Gene ID
17395, http://www.ncbi.nlm.nih.gov/sites/
entrez?db=gene) and compared airway injury
responses with O3 relative to corresponding
wild-type control mice.
Materials and Methods
Animals and inhalation exposure. Male (6–8
weeks old, 20–25 g) C57BL/6J (Mmp7+/+) and
B6.129-Mmp7tm1Lmm/J (Mmp7–/–), FVB/NJ
(Mmp9+/+), and FVB.Cg-Mmp9tm1Tvu/J
(Mmp9–/–) mice were purchased from The
Jackson Laboratory (Bar Harbor, ME).
Inhalation exposures were performed in a bar-
rier facility at Alion Science and Technology,
Inc. (Research Triangle Park, NC). After accli-
mation, mice were placed in individual stain-
less-steel wire cages within a Hazelton 1000
chamber (Lab Products, Maywood, NJ)
equipped with a charcoal and high-efﬁciency
particulate air-ﬁltered air supply. Mice had free
access to water and pelleted open-formula
rodent diet NIH-31 (Zeigler Bros, Inc.,
Gardners, PA). Mice were exposed continu-
ously to 0.3 ppm O3 for 6, 24, 48, or 72 hr.
O3 was generated from ultra-high purity air
(< 1 ppm total hydrocarbons; National
Welders, Inc., Raleigh, NC) using a silent arc
discharge O3 generator (Model L-11; Paciﬁc
Ozone Technology, Benecia, CA). Constant
chamber air temperature (72 ± 3°F) and rela-
tive humidity (50 ± 15%) were maintained.
O3 concentration was continually monitored
(Dasibi model 1008-PC, Dasabi Environ-
mental Corp., Glendale, CA). Parallel exposure
to filtered air was conducted in a separate
chamber for 48 hr. All animal use was
approved by the National Institute of
Environmental Health Sciences Animal Care
and Use Committee, and all animals were
treated humanely and with regard for allevia-
tion of suffering.
Lung bronchoalveolar lavage ﬂuid (BALF)
and cell preparation. Immediately after expo-
sure to air or O3, mice were euthanized with
sodium pentobarbital (104 mg/kg). After 24-
or 48-hr exposure, BAL was performed in situ
4 times with Hanks balanced salt solution
(35 mL/kg; pH 7.2–7.4). These time points
were chosen for BAL procedures on the basis
of previous investigations with multiple inbred
strains of mice that indicated inflammation
and injury peaked between 24 and 48 hr
during continuous exposure to 0.3 ppm O3
(e.g., Cho et al. 2007; Dahl et al. 2007;
Kleeberger et al. 1993). Recovered BALF was
immediately cooled in ice and centrifuged
(1,000 × g, 10 min). The cell pellets were
resuspended in 1 mL of Hanks balanced salt
solution, and the cells were counted with a
hemacytometer. Aliquots (150 µL) were cyto-
centrifuged, and the cells were stained with
Wright-Giemsa stain solutions (Fisher
Scientiﬁc, Pittsburgh, PA) for differential cell
analysis (markers of cellular inﬂammation and
epithelial injury). The supernatants from the
ﬁrst BALF return were assayed for total pro-
tein (a marker of lung permeability) with the
Bradford assay (Bradford 1976).
Lung tissue preparation for histopathology
and immunohistochemistry. Left lung lobes
from mice exposed to either 0.3 ppm O3 or
ﬁltered air for 48 hr were inﬂated gently with
zinc formalin, fixed at a constant pressure
(25 cm) of the same ﬁxative for 30 min, tied
off at the trachea, and immersed in the ﬁxa-
tive for 1 day. Proximal and distal intrapul-
monary axial airway was excised, embedded
in parafﬁn, and sectioned (5 µm). Tissue sec-
tions were histochemically stained with hema-
toxylin and eosin (H&E) for morphological
comparison of pulmonary injury between
genotypes. The terminal bronchioles and
alveoli were the primary focus of study
because 48-hr exposure to 0.3 ppm O3 causes
histologically evident inflammation and
epithelial lesions in these regions of the mouse
lung. Separate tissue sections from Mmp9+/+
or Mmp9–/– mice were immunologically
stained using a goat anti-mouse MMP-9 anti-
body (R&D Systems, Inc., Minneapolis,
MN) or a rat anti-mouse Ki-67 antibody
(Dako North American, Inc., Carpinteria,
CA) to localize MMP-9 and Ki-67, respec-
tively, using the standard peroxidase–
diaminobenzidine (DAB) method.
Western blot analysis. Equal amounts of
total lung protein (45 µg) isolated from mouse
lung homogenates (air or 24, 48, and 72 hr of
O3) in radioimmunoprecipitation (RIPA)
buffer (1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate
(SDS), 10 g phenylmethylsulfonyl fluoride/
mL, 1 mM sodium orthovanadate, 1× protease
inhibitor cocktail in 1× phosphate-buffered
saline) were separated on 10–20% SDS gel
electrophoresis gels. The 24-, 48-, and 72-hr
time points were chosen for investigation to
characterize the kinetics of lung MMP activ-
ity changes induced by O3 exposure. Proteins
were then transferred to a polyvinylidene
ﬂuoride (PVDF) membrane. The membrane
was blocked for 2 hr at room temperature
with 5% nonfat milk in Tris-buffered
saline–Tween buffer (20 mmol/L Tris,
500 mmol/L NaCl, 0.01% Tween 20). The
blot was then incubated at 4°C overnight
with anti-MMP-9 (R&D Systems), anti-
MMP-2 (R&D Systems), or an anti-actin
antibody (SantaCruz Biotechnology Inc., Santa
Cruz, CA) as an internal control, followed
by incubation for 1–2 hr with the proper
secondary horseradish peroxidase-conjugated
antibodies. The immunoblot was visualized
through enhanced chemiluminescence.
Total RNA isolation and real-time quanti-
tative reverse transcriptase–polymerase chain
reaction (RT-PCR). Total RNA from frozen
lungs (air or 6, 24, and 48 hr of O3) was iso-
lated using the RNeasy Midiprep kit (QIA-
GEN, Valencia, CA). The 6-hr time point was
included in this protocol to optimize the likeli-
hood of capturing early inflammatory
cytokine/chemokine gene expression on the
basis of previous experience with this model
(Cho et al. 2007). One microgram total RNA
was reverse transcribed into cDNA in a volume
of 50 µL containing 1× PCR buffer [50 mM
KCl and 10 mM Tris (pH 8.3)], 5 mM
MgCl2, 1 mM each dNTPs, 125 ng oligo
(dT)15, and 50 U of Moloney murine leuke-
mia virus reverse transcriptase (Invitrogen Life
Technologies, Carlsbad, CA), at 45°C for
15 min and 95°C for 5 min using the Gene
Amp PCR System 9700 (Applied Biosystems,
Foster City, CA).
An aliquot (2–5 µL) of the reverse tran-
scriptase product (equivalent to 40–100 ng
RNA) was ampliﬁed using PowerSYBR gene
expression assays on the 7700 Prism sequence
detection system (Applied Biosystems). The
PCR conditions and data analysis were per-
formed according to the manufacturer’s proto-
col in User Bulletin no. 2, “Applied Biosystems
Prism 7700 Sequence Detection System”
(Applied Biosystems 2007). Quantiﬁcation of
gene expression was determined by the num-
ber of cycles to threshold (CT) of ﬂuorescence
detection. Relative gene expression was deter-
mined using the comparative CT method as
described previously (Chakrabarti and Patel
2005). Brieﬂy, the ΔCT value was obtained by
subtracting the 18s rRNA CT value from the
CT value of the gene tested in the same sam-
ple. Message levels of each gene were expressed
as fold changes relative to those in Mmp9+/+
air controls.
Gelatin zymography analysis. Equal vol-
umes of BALF (10 µL) samples were loaded
on 10% Tris–glycine gel with 0.1% gelatin
(Invitrogen Life Technologies) for elec-
trophoresis. To eliminate the SDS content,
the gels were washed with 2.7% (wt/vol)
Triton X-100 at room temperature for 30 min
and incubated for 16 hr in a buffer containing
50 mM Tris base, 40 mM HCl, 200 mM
NaCl, 5 mM CaCl2, and 0.02% (wt/vol)
Brij 35 for gelatinolytic enzymes to act. The
digested gels were stained in Colloidal Blue
Staining kit (Bio-Rad Laboratories, Hercules,
CA) for 4 hr to visualize the gelatin activity.
Yoon et al.
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Doc 2000 System (Bio-Rad).
Cytokine enzyme-linked immunosorbent
assay (ELISA). Immunoreactive macrophage
inﬂammatory protein-2 [MIP-2, human inter-
leukin-8 (IL-8) analogue, similar to chemokine
(C-X-C motif) ligand (CXCL) 1 and 2] and
keratinocyte-derived chemokine [KC, human
growth-regulated oncogene (GRO)-α analogue,
similar to CXCL1, 2, and 3] were quantiﬁed in
aliquots of BALF (50 µL) using commercially
available ELISA kits (R&D Systems), accord-
ing to the manufacturer’s instructions. Each
cytokine quantity was calculated from
absorbance at 450 nm using a standard curve.
Statistics. All data are expressed as group
means ± SE. Two-way analysis of variance
(ANOVA) was used to evaluate the effects of
subacute O3 exposure on lung injury parame-
ters between Mmp7+/+ and Mmp7–/– or
Mmp9+/+ and Mmp9–/– mice. The factors in
the analysis were exposure (air vs. O3) and
genotype (Mmp7+/+ vs. Mmp7–/–, Mmp9+/+
vs. Mmp9–/–). The dependent variables were
protein level, cell number, MMP-2 activity,
and cytokine concentrations in BALF, and
lung protein and mRNA levels. One-way
ANOVA was used to evaluate the effect of O3
on MMP-9 production and expression in
Mmp9+/+ mice. The Student–Newman–Keuls
test was used for a posteriori comparisons of
means. All analyses were performed using a
commercial statistical analysis package
(SigmaStat; SPSS Inc., Chicago, IL). Statistical
signiﬁcance was accepted at p < 0.05.
Results
Roles of MMP-7 and MMP-9 in O3-induced
airway inflammation. The roles of MMP-7
and MMP-9 in O3-induced airway inﬂamma-
tion were assessed by exposing Mmp7+/+,
Mmp7–/–, Mmp9+/+, and Mmp9–/– mice
continuously to air or O3 for 24 and 48 hr.
No signiﬁcant differences in mean BAL pro-
tein concentration or cell numbers were found
between respective +/+ and –/– genotypes
after exposure to air (Figure 1, Table 1). After
48 hr of O3 exposure, BAL protein concentra-
tion was signiﬁcantly (p < 0.05) increased in
all four genotypes (Figure 1, Table 1). The
BALF protein concentration was signiﬁcantly
greater (68%) in Mmp9–/– mice compared
with Mmp9+/+ mice (Figure 1A); however, no
signiﬁcant differences in protein concentration
were found between Mmp7+/+ and Mmp7–/–
mice after exposure to O3 (Table 1). O3
caused signiﬁcant increases in the mean num-
bers of BAL neutrophils in Mmp9+/+ and
Mmp9–/– mice after 48 hr of O3 exposure (p <
0.05; Figure 1B). However, compared with
Mmp9+/+ mice, O3-enhanced BAL neutrophil
numbers were significantly higher in
Mmp9–/–mice (p < 0.05). Mean numbers of
epithelial cells were also signiﬁcantly greater in
Mmp–/– mice relative to those in Mmp+/+ mice
after 24- and 48-hr O3 exposure (p < 0.05;
Figure 1C). No signiﬁcant differences in the
number of BALF alveolar macrophages were
found between Mmp9+/+ and Mmp9–/– mice
(data not shown). No signiﬁcant differences in
mean numbers of BALF inflammatory cells
were found between Mmp7–/– and Mmp7+/+
mice after exposure to O3 (Table 1).
Effect of O3 on MMP-2 and MMP-9
expression in the lung. We performed gelatin
zymogram and Western blot analyses on BALF
and lung protein extracts from Mmp9+/+ and
Mmp9–/– mice to determine whether produc-
tion of MMP-2 and MMP-9 was augmented
by O3 exposure. Both gelatinases have been
implicated in the pathogenesis of inflamma-
tion-related lung diseases (e.g., Pardo et al.
1998; Tan et al. 2006); we also reasoned that
MMP-2 expression might be enhanced to
compensate for MMP-9 deletion. Minimal
gelatinase activity was found in BALF from
either genotype after air exposure. Exposure to
O3 (48 and 72 hr) caused signiﬁcant (p < 0.05)
increase in MMP-9 activity at 92 kDa (latent
form) and 88 kDa (active form) in BALF from
Mmp9+/+ mice (Figure 2A). Western blot
analyses confirmed O3-induced increase in
MMP-9 protein levels in lung homogenates
from Mmp9+/+ mice (Figure 2B). Furthermore,
lung MMP-9 mRNA expression in Mmp9+/+
mice was signiﬁcantly increased compared with
air controls after 6 hr of O3 and remained
increased by 48-hr exposure (p < 0.05;
Figure 2C). MMP-9 proteins were localized
primarily in alveolar epithelial cells, inﬁltrating
inﬂammatory cells, endothelial cells, and cells
in the injured parenchyma of Mmp9+/+ mice
after O3 exposure (Figure 3).
Basal levels of MMP-2 protein and activity
were detectable in lung protein extract and
BALF, respectively, from Mmp9+/+ and
Mmp9–/– mice, although no differences were
detected between genotypes. O3 increased
MMP-2 activity and production in both geno-
types compared with corresponding baseline
(Figure 4A,B), but the increases were signiﬁ-
cantly (p < 0.05) greater in Mmp9–/– com-
pared with Mmp9+/+ mice.
Effects of Mmp9 deﬁciency on O3-induced
pulmonary pathology. H&E-stained lung sec-
tions from Mmp9+/+ and Mmp9–/– mice
exposed to air were normal, and no histologi-
cal differences were found between them
(Figure 5A,5C). After 48 hr of O3 exposure,
signiﬁcant peribronchiolar inﬂammation and
proliferation as well as epithelial hyperplasia
in terminal bronchioles were detected in
Mmp9+/+ and Mmp9–/– mice (Figure 5B,D).
MMP-9 attenuates lung injury caused by O3
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Table 1. Effect of Mmp7 deﬁciency on BALF protein and cell differentials after O3 exposure (0.3 ppm for 48 hr).
Genotype Proteins (µg/mL) Macrophages (×103/mL) Neutrophils (×103/mL) Epithelial cells (×103/mL)
Mmp7+/+ (Air) 107.0 ± 6.7 21.8 ± 2.8 0.1 ± 0.1 1.7 ± 0.2
Mmp7–/– (Air) 140.0 ± 4.7 23.5 ± 1.9 0.02 ± 0.02 1.5 ± 0.3
Mmp7+/+ (O3) 540.8 ± 32.1* 47.6 ± 2.2* 5.9 ± 1.5* 3.0 ± 0.5
Mmp7–/– (O3) 707.5 ± 73.1* 49.7 ± 4.4* 10.0 ± 3.3* 7.1 ± 1.2*
Results are the means ± SE for 5–8 mice in each group. *Signiﬁcantly different from genotype-matched air control mice (p < 0.05).
Figure 1. Concentration of total protein (A) and numbers of neutrophils (B) and epithelial cells (C) in BALF recovered from Mmp9+/+ and Mmp9–/– mice after
exposure to 0.3 ppm O3 or ﬁltered air. Data are presented as means ± SE (n = 8–10/group). 
*Signiﬁcantly different from genotype-matched air control mice (p < 0.05). #Signiﬁcantly different from exposure-matched Mmp9+/+ mice (p < 0.05).
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A B CHowever, O3 caused more severe epithelial
thickening, inflammation, and alveolar vac-
uolization in the terminal bronchioles of
Mmp9–/– compared with Mmp9+/+ mice
(Figure 5D). Enhanced airway cellular prolif-
eration was also more severe in the absence of
MMP-9 as determined by immunohistochem-
istry of Ki-67–positive cells in G/S phases of
the cell cycle (Figure 6). Nuclear localization
of Ki-67 was mainly found in inflammatory
cells and in cells of the terminal bronchioles
that were injured by O3.
Effect of Mmp9 deﬁciency on protein lev-
els and mRNA expression of the neutrophil
chemokines KC and MIP-2. To investigate the
mechanism for increased neutrophil recruit-
ment to the airway in the absence of MMP-9,
we used ELISA to measure BALF levels of
chemokines known to be involved in neu-
trophil chemotaxis (KC and MIP-2). No sig-
niﬁcant genotype-speciﬁc differences in mean
concentrations of KC or MIP-2 were found
after exposure to air (Figure 7). Mean KC and
MIP-2 concentrations were significantly
increased in BALF by O3 exposure in both
genotypes (p<   0.05, Figure 7). However, con-
sistent with BALF inflammatory parameters
and pathology (Figures 1, 5, and 6), KC and
MIP-2 levels were significantly (p<   0.05)
greater in Mmp9–/– mice compared with
Mmp9+/+ mice after 24- and 48-hr exposure to
O3 (Figure 7). KC and MIP-2 mRNA levels
were not different between genotypes after
exposure to air. After 24- and 48-hr exposure
to O3, KC and MIP-2 mRNA was increased
significantly (p<   0.05) over the air controls
in both genotypes but, interestingly, no dif-
ferences were found between genotypes
(Figure 8).
Discussion
O3-induced airway inﬂammation is character-
ized by early neutrophilic inﬁltration followed
by a mononuclear cell dominated inﬂamma-
tion (Chitano et al. 1995). Molecular changes
during the pulmonary pathogenesis induced
by O3 include increased production of
prostaglandins, proinflammatory cytokines,
and chemokines such as IL-6, IL-8, granulo-
cyte macrophage colony-stimulating factor,
KC, and MIP-2 (Devlin et al. 1991; Johnston
et al. 2005a). In humans, neutrophil influx
begins in peripheral airways as early as 6 hr
after O3 exposure and is known to be medi-
ated by neutrophilic chemokines such as IL-8
Yoon et al.
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Figure 3. Immunohistochemical localization of MMP-9 in the lungs of Mmp9+/+ mice after ﬁltered air
(A) and 48-hr O3 (B,C,D) exposure. Representative light micrographs at higher magniﬁcations (D) show
MMP-9–positive cells (in brown) including alveolar epithelial cells, infiltrating inflammatory cells,
myoﬁbroblasts, and cells in the injured regions undergoing proliferation and differentiation. Lung tis-
sue sections from Mmp9–/– mice exposed to O3 (E) were similarly processed and visualized as nega-
tive controls. Abbreviations: av, alveoli; bv, blood vessels; tb, terminal bronchioles. Bars = 50 µm.
AD
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Figure 2. MMP-9 mRNA, protein, and activity
after exposure to 0.3 ppm O3 or filtered air.
(A) Representative images of MMP-9 activity in
BALF from Mmp9+/+ mice determined by gelatin
zymogram after exposure to 0.3 ppm O3 (24, 48, 72
hr) or ﬁltered air (n = 3/group). (B) Representative
Western blots of MMP-9 in pooled lung
homogenates from Mmp9+/+ (+/+) and Mmp9–/–
(–/–) mice after exposure to 0.3 ppm O3 (24, 48, 72
hr) or ﬁltered air (n = 3/group). (C) MMP-9 mRNA
expression in lung homogenates from Mmp9+/+
mice after exposure to 0.3 ppm O3 (6, 24, 48 hr) or
filtered air. Quantitative real-time PCR-deter-
mined fold increase of normalized expression to
18s rRNA compared with air-exposed mice (n =
3/group). Data are presented as means ± SE. 
*Signiﬁcantly different from air control mice (p < 0.05).
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*and GRO-α (Krishna et al. 1998). Functional
roles of several inﬂammatory mediators such
as tumor necrosis factor-α (TNF-α) (Cho
et al. 2001; Kleeberger et al. 1997), IL-6
(Johnston et al. 2005b), and IL-1β (Arsalane
et al. 1995), and the transcription factors
nuclear factor kappa B (Cho et al. 2007;
Laskin et al. 2002) and activator protein
(AP)-1 (Cho et al. 2007) have also been
determined in pulmonary inflammation of
laboratory rodents exposed to O3.
The primary functions of MMPs include
degradation and turnover of ECM, tissue
repair and remodeling, and leukocyte migra-
tion from peripheral circulation to inﬂamma-
tory sites. Furthermore, recent findings
suggested that MMPs can modulate inflam-
mation and innate immunity by affecting the
activity of various nonmatrix proteins (Parks
et al. 2004). MMP-9 has been thought to be
particularly important in the pathogenesis of
inflammatory lung diseases, including acute
lung injury, asthma, and COPD (Atkinson and
Senior 2003). Higher than normal MMP-9
levels in the patients with these disorders may
promote destruction of normal tissue archi-
tecture and increased migration of inﬂamma-
tory cells to the disease sites (Lemjabbar et al.
1999a, 1999b).
In the present study, we hypothesized that
MMP-9 is essential for O3-induced airway
inflammation because MMP-9 is one of the
most predominant MMPs found in inflam-
matory airway diseases (Atkinson and Senior
2003). Contrary to predictions, we found
that O3-induced neutrophilic airway inﬂam-
mation and injury were markedly increased in
Mmp9–/– mice compared with Mmp9+/+ mice,
indicating a protective role of MMP-9 in
MMP-9 attenuates lung injury caused by O3
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Figure 5. Lung histology from Mmp9+/+ (A,B) and Mmp9–/– (C,D) mice exposed to air (A,C) and 48 hr O3
(B,D). Parafﬁn-embedded left lung tissue sections were stained with H&E for histopathologic analysis.
Representative light micrographs show more severe epithelial thickening, inﬂammation, and alveolar
vacuolization in distal airways of Mmp9–/– mice (D) relative to those of Mmp9+/+ mice (B) exposed to
O3. Abbreviations: av, alveoli; bv, blood vessels; tb, terminal bronchioles. Bars = 100 µm.
A
B
C
D
Figure 6. Cell proliferation in lungs of Mmp9+/+ (A,B) and Mmp9–/– (C,D) mice exposed to air (A,C) and
48 hr O3 (B,D). Ki-67–positive cells in G/S phases of the cell cycle were detected immunohistochemi-
cally, and representative light photomicrographs display nuclear localization of Ki-67 (brown dots) in
cells of severely injured terminal bronchioles. Abbreviations: av, alveoli; bv, blood vessels; tb, terminal
bronchioles. Bars = 50 µm.
A
B
C
D
Figure 4. Measurement of MMP-2 in BALF and
lung protein extracts from Mmp9+/+ and Mmp9–/–
mice after exposure to ﬁltered air or 0.3 ppm O3.
(A) Representative Western blot image of
MMP-2 protein expression in pooled lung
homogenates from Mmp9+/+ (+/+) and Mmp9–/–
(–/–) mice after exposure to 0.3 ppm O3 (24, 48, 72
hr) or ﬁltered air (n = 3/group). (B) Representative
gelatin zymogram image for MMP-2 activity in
BALF from Mmp9+/+ (+/+) and Mmp9–/– (–/–) mice
after exposure to 0.3 ppm O3 (48 hr) or ﬁltered air.
Relative optical density of MMP-2 activity quanti-
ﬁed from zymogram blots. Data are presented as
means ± SE (n = 3/group). 
*Significantly different from genotype-matched air control
mice (p < 0.05). #Significantly different from O3 (48 hr)-
exposed Mmp9+/+ mice (p < 0.05).
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Mmp9 –/–O3-exposed airways. The results from the cur-
rent study suggest that MMP-9 may not act
primarily on ECM degradation that facilitates
leukocyte migration to pulmonary inﬂamma-
tory sites as indicated by another investigation
(Betsuyaku et al. 1999). Heightened neu-
trophilic inflammation was also associated
with enhanced levels of KC and MIP-2,
which are important chemokines for neu-
trophil recruitment to the lung.
MMP-9 has diverse effects on neutrophilic
inﬂammation in experimental animal models.
It enhances neutrophil chemotaxis in response
to certain chemokines (D’Haese et al. 2000)
and increases neutrophil influx in glomeru-
lonephritis (Sternlicht and Werb 2001).
Conversely, MMP-9 also has inhibitory effects
on BALF neutrophilia (Lanone et al. 2002);
increased tissue neutrophil and inﬂammatory
cell inﬁltration have been shown in Mmp9–/–
mice in response to epithelial injury and
chemokine administration (D’Haese et al.
2000; Mohan R et al. 2002). Several lines of
molecular evidence have determined that pro-
teolytic function of MMP-9 affects cytokine
and chemokine levels as well as their activities.
For example, MMP-9 processes and activates
pro-IL-1β (Schonbeck et al. 1998), inactive
membrane bound forms of TNF-α (Mohan
MJ et al. 2002), and transforming growth fac-
tor-β (TGF-β) (Yu and Stamenkovic 2000).
MMP-9 also processes CXC chemokines,
which exert potent chemoattractant activities
on leukocytes and alters their specific activi-
ties, but not CC chemokines (e.g., RANTES
and MCP-2) (Van den Steen et al. 2000).
MMP-9 truncates IL-8 (1–77) into IL-8
(7–77), which enhances neutrophil activation
more than 10-fold (Van den Steen et al.
2000). In contrast, neutrophilic chemoattrac-
tant activity was decreased by MMP-9 degra-
dation of the other CXC chemokines GRO-α
and connective tissue–activating peptide
(CTAP)-III (Van den Steen et al. 2000). Our
current observation that O3 induced higher
levels of BAL CXC chemokines KC and
MIP-2 in Mmp9–/– mice than in Mmp9+/+
mice is consistent with, but does not prove,
the notion that these chemokines were key
effectors of pulmonary MMP-9. Interestingly,
we also found no differences in the steady state
mRNA levels of the O3-increased KC and
MIP-2 between Mmp9+/+ and Mmp9–/– mice.
Together these results suggest that differences
in these chemokine levels in Mmp9–/– mice
compared with those in Mmp9+/+ mice were
caused by translational or posttranslational
processes, which may include degradation/
cleavage by MMP-9.
Signiﬁcantly greater elevation of MMP-2
level and activity were observed in Mmp9–/–
mice compared with Mmp9+/+ mice after O3
exposure. We cannot rule out the possibility
that increased MMP-2 is a compensatory
response in Mmp9–/– mice and may be
involved in increased neutrophilic airway
inflammation. However, MMP-9 has been
reported to be the dominant airway MMP
controlling inflammatory cell egression
(Corry et al. 2004), and there is no evidence
that MMP-2 has a modulating effect on
inflammatory chemokines such as KC and
MIP-2 (Parks et al. 2004). In addition,
neutrophil concentrations in BALF were not
changed in Mmp2–/– mice in a model of aller-
gic asthma (Corry et al. 2002). We therefore
postulate that MMP-2 does not have a critical
role in heightened neutrophilic inﬂammation
in Mmp9–/– mice, although it may be
involved with other mechanisms of lung
injury induced by O3 exposure (e.g., lung
hyperpermeability).
The role of MMP-7 in acute lung injury
has been studied in mouse models of intersti-
tial pulmonary diseases such as fibrosis:
Mmp7–/– mice had suppressed pulmonary
ﬁbrosis caused by bleomycin (Li et al. 2002;
Zuo et al. 2002), and it was accompanied by
decreased neutrophilic inflammation and
chemokines (e.g., KC) in the alveolar ﬂuid (Li
et al. 2002). We predicted that O3-induced
airway inﬂammation would be attenuated in
Mmp7–/– mice. However, the current ﬁndings
suggest that MMP-7 is not signiﬁcantly asso-
ciated with O3-induced airway inﬂammation
and injury in mice. In addition, KC concen-
trations in BALF were not signiﬁcantly differ-
ent between Mmp7–/– and Mmp7+/+ mice in
the current model (data not shown). No stud-
ies have investigated the role of MMP-7 in
oxidative lung injury such as O3. Different
from MMP-9, matrilysin is produced by alve-
olar epithelial cells in injured lungs, and it has
been thought to contribute to alveolar epithe-
lial injury and re-epithelialization. Inhaled O3
mostly affects centriacinar legions of the air-
way, but not alveoli, which may partially
explain why MMP-7 deﬁciency failed to alter
airway inﬂammation by O3.
In summary, our results showed that deﬁ-
ciency in MMP-9 was associated with
enhanced airway epithelial injury, neutrophil
recruitment, and permeability following O3
exposure, but a deﬁciency in MMP-7 did not
signiﬁcantly affect O3-induced airway injury.
The aberrant neutrophil recruitment was corre-
lated with increased levels of KC and MIP-2
protein, but not mRNA expression, in the
Mmp9–/– mice relative to Mmp9+/+ mice.
Results are consistent with the hypothesis that
enhanced O3-induced injury in Mmp–/– mice is
related to a difference in posttranscriptional
processing of these CXC chemokines in the air-
way. These ﬁndings increase our understanding
of the pathophysiological process of O3-
induced lung injury and suggest that MMP-9
produced in the lung in response to oxidative
stimuli may have a beneﬁcial function.
Yoon et al.
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Figure 7. Protein levels of neutrophil chemokines KC (A) and MIP-2 (B) in BALF from Mmp9+/+ and
Mmp9–/– mice exposed to air and 0.3 ppm O3. Data are presented as means ± SE (n = 7–8/group). 
*Signiﬁcantly different from genotype-matched air control mice (p < 0.05). #Signiﬁcantly different from exposure-matched
Mmp9+/+ mice (p < 0.05).
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Figure 8. mRNA expression of neutrophilic chemokines KC (A) and MIP-2 (B) in Mmp9+/+ and Mmp9–/–
mice exposed to air and 0.3 ppm O3. Quantitative real time PCR determined fold increase of message
expression normalized to18s rRNA compared with air exposed Mmp9+/+ mice (n = 3/group). Data are
presented as means ± SE (n = 3/group). 
*Signiﬁcantly different from genotype-matched air control mice (p < 0.05).
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